Dolby Laboratories (NYSE:DLB) CEO Sells $453,937.24 in Stock

Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman sold 6,751 shares of the stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $67.24, for a total value of $453,937.24. Following the completion of the sale, the chief executive officer directly owned 98,377 shares of the company’s stock, valued at approximately $6,614,869.48. This trade represents a 6.42% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Dolby Laboratories Trading Down 0.8%

Shares of Dolby Laboratories stock opened at $66.26 on Friday. The stock has a fifty day simple moving average of $66.78 and a 200 day simple moving average of $71.16. Dolby Laboratories has a 12-month low of $64.02 and a 12-month high of $89.66. The company has a market capitalization of $6.33 billion, a P/E ratio of 25.19 and a beta of 0.89.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business had revenue of $307.02 million for the quarter, compared to analysts’ expectations of $305.76 million. During the same period last year, the business earned $0.61 EPS. The business’s revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, analysts predict that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.2%. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date was Tuesday, December 2nd. Dolby Laboratories’s dividend payout ratio is presently 54.75%.

Institutional Trading of Dolby Laboratories

A number of large investors have recently bought and sold shares of the company. Cetera Investment Advisers lifted its position in shares of Dolby Laboratories by 6.1% during the 1st quarter. Cetera Investment Advisers now owns 4,883 shares of the electronics maker’s stock valued at $392,000 after buying an additional 282 shares during the last quarter. Nuveen LLC purchased a new stake in Dolby Laboratories during the first quarter valued at about $16,890,000. Russell Investments Group Ltd. lifted its holdings in Dolby Laboratories by 53.7% during the first quarter. Russell Investments Group Ltd. now owns 62,918 shares of the electronics maker’s stock valued at $5,051,000 after purchasing an additional 21,994 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Dolby Laboratories during the first quarter worth about $29,000. Finally, Ethic Inc. purchased a new position in shares of Dolby Laboratories in the first quarter worth about $536,000. 58.56% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on DLB shares. Robert W. Baird started coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 target price on the stock. Rosenblatt Securities decreased their price target on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Wednesday, November 19th. Barrington Research reduced their price objective on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Baird R W raised Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $92.00.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.